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ABSTRACT
Astronauts are at risk for developing decompression sickness (DCS) while exposed to the hypobaric
environment of the extravehicular suit in space, in terrestrial hypobaric chambers, and during ascent from
neutral buoyancy training dives. There is increasing recognition that DCS risk is different between diving
and altitude exposures, with many individual parameters and environmental factors implicated as risk
factors for development of DCS in divers but are not recognized as risk factors in altitude exposures.
Much of the literature to date has focused on patent foramen ovale (PFO), which has long been
considered a major risk factor for DCS in diving exposures, but its link to serious DCS in altitude
exposures remains unclear. Knowledge of those risk factors specific to hypobaric DCS may help identify
susceptible individuals and aid in astronaut selection, crew assignment, and mission planning. This paper
reviews the current literature pertaining to these risk factors, including PFO, anthropometric parameters,
gender, menstrual cycle, lifetime diving experience, physical fitness, biochemical levels, complement
activation, cigarette smoking, fluid balance, and ambient temperature. Further research to evaluate
pertinent risk factors for DCS in altitude exposures is recommended.
INTRODUCTION
Absolute or relative reductions in ambient pressure, as experienced during extravehicular activity,
physiological training in hypobaric chambers, or ascent from diving place unique stressors on the human
body. Participants in these environments are at risk for the development of decompression sickness
(DCS), whose symptoms range from mild musculoskeletal pain to serious neurological deficits to death.
Given the potential negative impact on crew health and mission success, it would be invaluable to identify
risk factors for DCS and employ preventive strategies to mitigate the risk.
DCS occurs as a result of transitioning from one environment to a more hypobaric environment. When
the ambient pressure decreases, nitrogen dissolved in the bloodstream comes out of solution and forms
bubbles, which may remain locally or may be transported into the venous system. Most bubbles are
trapped in the pulmonary capillary bed before being quickly resorbed, but if the pulmonary filter gets
overwhelmed or bypassed due to an anatomic defect allowing for right-to-left shunt, these bubbles may
become arterial gas emboli and result in local ischemia anywhere in the body.
:KLOHTy 6\HIHD , SH( &6ainHonDLor mild lymphatic involvement) generally requires no treatment or brief
treatment with 100% oxygen, Type II DCS can manifest with pulmonary, cardiovascular, or neurologic
symptoms that are more difficult to treat and may result in significant morbidity or mortality (Francis
1990). The Exploration Medical Capability Program has been tasked with reviewing what is known
about individual susceptibility to hypobaric environments²specifically, DCS. This white paper will
summarize the work done by the Patent Foramen Ovale Committee and Medical Operations EVA
Integrated Product Team in 1999, review the literature on PFO since 1999, and discuss other risk factors
for DCS that have been proposed.
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PATENT FORAMEN OVALE & DECOMPRESSION SICKNESS
Patent foramen ovale (PFO), the primary means of arterial gas embolism through the heart that has been
implicated in an LdGL7 LG3s7 sWibiliX3tU3DCW,3iELcommon remnant of fetal circulation when the
atrial septum primum and septum secundum fail to fuse during the first months of life, enabling abnormal
blood flow between the left and right atria. Some PFOs open only when there is an increase in pulmonary
pressure²e.g., during a Valsalva maneuver or strenuous activity²but some PFOs are persistently open
and believed to be more dangerous since they pose a constant threat for arterializations of gas bubbles
(Medical Operations EVA IPT 1999). An autopsy study reported that the overall incidence of PFO in 965
subjects was 27.3% with a median diameter of 5 mm; 9.7% of the subjects had a PFO greater than 5 mm
(Hagen 1984). The incidence of resting PFO was reported to be 5 to 10% in the literature and might be as
high as 21% in the experience of the JSC Cardiovascular Laboratory (Waligora 1999).
Concern about the role of PFO in the development of decompression sickness arose from diving data.
Studies have shown that divers with a PFO have a 2.5 to 4.5 fold increase in the risk of developing type II
DCS (Bove 1998, Drighil 2007). To date, PFO has been the most studied risk factor of DCS, although its
role in altitude exposures remains controversial for a number of reasons, including the lack of a
standardized technique for detecting PFOs and uncertainty about the exact incidence of DCS.
PFO Committee/Medical Operations EVA IPT
In 1999, a NASA-sponsored committee was tasked with reviewing data on PFO and making
recommendations about the merit of PFO screening in the astronauts and test subjects. The Medical
Operations EVA Integrated Product Team (q OH3Ops3VVq (3I$ T,3s7 bse VeEV3reXHeWOe3c UmYLeZs 3 q WKH q FRPP:
recommendations and consulted outside experts to develop a consensus position on PFO screening.
Despite the strength of evidence in diving exposures, PFO had not been directly linked to Type II DCS in
altitude exposures. A retrospective study by the Navy found no association between PFO and Type II
DCS in 45 aviators who presented with Type II DCS symptoms related to altitude physiological training
(Gallagher 1996).
In an Air Force altitude chamber-based study in which 1,500 volunteer subjects were monitored for gas
emboli simultaneously in the right and left sides of the heart at simulated altitude, six subjects were found
to have right-to-left gas crossover; five of these subjects were symptomatic with joint pain or skin
mottling (but no cerebral symptoms) at the time of arterial gas embolism. Of the six cases, one was found
to have a PFO, one had a small sinus venosus defect, three had no septal defect, and one was not available
for evaluation (Pilmanis 1996). In another presentation, Pilmanis reported 39 cases of Type II DCS in
over 2000 research exposures simulating EVA exposures of 4-hour durations or longer, and none of these
subjects had detectable gas phase crossover during Trans Thoracic Echocardiography (TTE) monitoring
of all four cardiac chambers.
While no published study showed a statistically significant association between PFO and Type II DCS in
altitude exposures, case reports did suggest a relationship. Past hypobaric chamber research at JSC
identified five cases of Type II DCS. Three of these cases were tested: two (66%) were found to have a
PFO. Of note, four of the five cases did not prebreathe oxygen. A serious case of Type II DCS was
reported at Duke University during Phase III testing of the Prebreathe Reduction Program, despite two
hours of oxygen prebreathe and albeit a less conservative nitrogen elimination protocol than the ISS
operational protocol. This subject was later determined to have a resting PFO.
Based on the available data, the PFO Committee recommended screening all individuals for high-risk
PFO, such as resting PFO, PFO in excess of 5 mm in diameter, or individuals with more than 20
countable bubbles observed passing through the PFO during a measurement. It was noted, however, that
some PFOs that opened only with provocation during strenuous EVA might have a greater diameter than
a smaller resting PFO. Furthermore, TTE with bubble contrast, the screening technique recommended by
the PFO Committee, had a sensitivity of 60 to 70%, JandJQMntifyGgJ“LIigLIJ)iQJ qLl 3)LJwas technically q
challenging and somewhat subjective. Transesophageal echocardiography was considered the gold
standard but invasive and not without risk.
The Med Ops EVA IPT noted that PFO screening could potentially eliminate 10 to 25% of EVA-
proficient crewmembers from the existing cadre of astronauts and severely limit the operational flexibility
of assigning crewmembers to station missions. Furthermore, given the limitations of PFO screening as
well as the unclear relationship between PFO and Type II DCS in altitude exposures, PFO screening
would not eliminate the risk of Type II DCS on orbit. A more effective means of mitigating the risk of
Type II DCS would be to minimize the chance of bubble formation by oxygen prebreathe procedures.
Taking tLIMJ qLl 3)JCFmmiPMM’sJ)McFmmMndatiFnsJandJMxD)nLJMxpM)tsDJ)MvVH into account, the Med Ops
EVA IPT recommended the following:
1. That NASA continue to eliminate astronaut candidates with flow-significant atrial septal defects
detected with TTE.
2. That an in-suit Doppler be implemented as soon as possible, and that an on-orbit operational
validation of the 2-hour prebreathe protocol be conducted.
3. That a multi-center retrospective study be initiated to determine the association between PFO and
Type II DCS in well-controlled altitude exposures, as a function of decompression stress.
4. That other prospective PFO studies be considered for funding.
5. That the possibility of screening out astronauts for high risk PFO continue to be considered as
warranted by new data or diagnostic modalities.
6. That sensitive screening methods for the risk of Type II DCS be developed, beyond screening for
PFO, i.e., screening for a combination of PFO and the propensity to produce high-grade venous
gas embolism, which would occur in a very small percentage of astronauts.
Beyond the Med Ops EVA IPT Report
Since 1999, other retrospective studies and meta-analyses have supported the relationship between PFO
and Type II DCS in divers. In a retrospective cohort study of 52 sport divers, Schwerzmann et al. (2001)
found a 4.5-fold increased risk for DCS in divers with PFO than those without a PFO. On MRI, almost
twice as many ischemic brain lesions were seen in divers with PFO, but the difference was not
statistically significant. The authors did not analyze the relationship between these brain lesions and
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DCS. Gempp et al. (2009) studied 49 divers with spinal cord DCS and found that divers with DCS were
3.6 times more likely than healthy divers to have a large right-to-left shunt on transcranial Doppler
ultrasonography; while shunting was not associated with an increased incidence of cervical spinal cord
DCS, divers with a right-to-left shunt were 6.9 times more likely to have thoracolumbar DCS. These
studies confirm the increased prevalence of PFO or right-to-left shunting in divers who experience DCS
and begin to offer a neuropathological basis for symptoms seen in Type II DCS.
New data also suggest that PFOs evolve as divers age. Anecdotally, some divers suddenly become
susceptible to DCS after an uneventful diving career of many years. A longitudinal study spanning 6 to 8
years found that the permeability of the foramen ovale in 40 divers changed; while 7.5% of the divers
who initially had a PFO saw closure of the PFO, 22.5% of the study cohort developed increased
permeability, half of whom had no initial PFO (Germonpré 2005).
In altitude exposures, it remains unclear whether PFO is a risk factor for Type II DCS. An evidence-
based literature review concluded that PFO could occur in altitude-induced DCS, but there was no
information beyond two case series to indicate causality (Straus 2001). Under-reporting of symptoms in
altitude conditions due to perceived negative career impact might partly explain the paucity of data.
It has been suggested that diving and altitude exposures are fundamentally different entities, as evidenced
by the observation that the most common symptoms of DCS at altitude are pain only, as opposed to
neurologic symptoms seen in recreational divers (Moon 2000); moreover, DCS symptoms tend to occur
during altitude exposure versus after diving exposure (Pilmanis 2004). Differences in duration of
exposure, prebreathe protocols, and oxygen use during exposure, as in the case of EVA, may further
account for the difference in diving and altitude data. Review of the literature since 1999 reveals that
additional research is needed to ascertain the relationship between PFO and Type II DCS in altitude
exposures. Thus, the benefit of screening astronauts for PFO remains unclear.
OTHER FACTORS AFFECTING INDIVIDUAL SUSCEPTIBILITY TO DCS
While patent foramen ovale has been studied the most, other risk factors for DCS have been proposed
based on known mechanisms, including bubble crossover through the heart, bubble crossover through the
lungs, and autochthonous bubbles. PFO and right-to-left shunting represent only the first mechanism.
Little is known about conditions that allow crossover through the lungs, which appear to have a threshold
for filtration of venous bubbles by the pulmonary vasculature, at least in dogs (Butler 1985). A variety of
individual parameters and environmental factors have been studied in an effort to identify risk factors for
autochthonous bubble formation that lead to susceptibility to DCS.
Individual Parameters
Parameters such as age, height, weight, body mass index, percent body fat, aerobic capacity, and gender
have been reported to influence DCS incidence (Sulaiman 1997, Conkin 2003, Webb 2003 and 2005). In
the most comprehensive study of these parameters to date, Air Force researchers sought to quantify
individual susceptibility to DCS and determine if the aforementioned variables could be used to predict
DCS risk. Retrospectively reviewing 2980 altitude exposures in the Air Force Laboratory Altitude DCS
Research Database, Webb et al. (2005) found that the combination of lower VO2max and greater weight
appeared to be the best predictor of DCS, but this accounted for less than 13% of the variation in DCS
susceptibility. The authors concluded that individual susceptibility to DCS could not be predicted by
these anthropometric and physiologic variables.
In another study, Webb et al. (2003) prospectively compared male and female subjects in 961 exposures
to simulated altitude and found no statistically significant difference in DCS incidence between men
(49.5%) and women (45.3%). Among women, they found no difference in DCS during the first two
weeks of the menstrual cycle between users of hormonal contraception vs. non-users. However, if only
the last half of the menstrual cycle were considered, hormonal contraception appeared to double the risk
of DCS, a finding supporting an earlier report by Doyle et al. (1997) but refuted by Lee et al (2003).
Lee and her colleagues surveyed 240 female sports divers treated with hyperbaric therapy for DCS in 23
treatment centers worldwide, and found the incidence of all DCS symptoms to be greatest in the first half
of the menstrual cycle (29 to 34%), with a marked fall in the third week (13 to 23%) before rising again in
the fourth week (21 to 25%); the trend was similar for Type I and Type II symptoms. The effect of
contraceptive use appeared to shift the occurrence of DCS to later in the cycle but there was no significant
difference between contraceptive users and non-users, although a statistically significant difference
existed between the two groups when age was taken into account. The observed differences in these
studies might have been due to differences in how menstrual history was recorded as well as doses and
formulation of contraceptives. More study is needed to draw a conclusion about the role of menstruation
and contraceptive use in the risk of DCS in women, and whether EVA schedules would need to be
adjusted accordingly.
An individual’s lifetime diving experience has also been linked to DCS risk. In a survey-based study of
429 subjects, Klingmann et al. (2008) found a 2.51-fold higher lifetime incidence of DCI in divers with a
history of deep dives greater than 40 meters compared to divers whose lifetime maximal depth was 40
meters or less. The relative risk of DCS between divers with 200 or fewer dives and “highly q q q RU q 1HZHU q GLYHV I
experienced” divers with more than 400 dives was 3.90. Similarly, certification to lower depths was
associated with 1.97 to 8.17 times higher incidence of DCS. There was no statistically significant
difference between technical divers and non-technical divers. Attrition, rather than any physiologic
factors, was identified as the explanation for the association between low-depth diving experience and
risk of DCS, but the authors did acknowledge a selection bias in their methodology and called for further
study before their results could be generalized to all divers. Similarly, prior DCS might predispose an
individual to subsequent development of DCS, but data have been limited to observations of caisson
workers in the 1970s (Francis 2003).
On the other hand, a more recent study suggested that repeated scuba dives and regular physical exercise
activity might protect against DCS, possibly due to reduced bubble formation (Pontier 2009). However,
exercise itself has been observed to offer protection from DCS. In addition to laboratory studies that
showed sedentary rats and pigs were more susceptible to severe DCS and death than exercise conditioned
groups (Broome 1995, Wisløff 2001), several human studies have found decreased venous gas emboli
formation, thereby inferring decreased DCS risk, in divers who exercised 24 hours before diving (Duji ć
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2004), 2 hours before diving (Blatteau 2005), during decompression (Jankowski 1997), and during a
decompression stop (Dujiii 2005). In altitude exposures, exercise during prebreathe (Gernhardt 2000,
Webb 2004) also appeared to be beneficial in preventing DCS.
Biochemically, limited studies have suggested that subjects susceptible to the formation of venous gas
emboli during decompression had significant higher levels of total cholesterol, high-density lipoprotein
cholesterol, potassium, phosphate, calcium, and magnesium (Jauchem 1986). A follow-on study was
unable to replicate these findings, and it was noted that factors such as prebreathe time, use of an
intermediate pressure stage, and length of time in the chamber could affect various biochemical
parameters (Jauchem 1990).
The observation that many of the effects of complement activation were similar to the symptoms of DCS
led to several studies that ultimately disproved complement activation as a risk factor for DCS. Ward et
al. (1987) found that the presence of air bubbles in plasma activated the complement system by the
alternate pathway and that subjects who were more sensitive to this complement activation were more
susceptible to DCS. However, in vivo testing failed to demonstrate this phenomenon and subjects who
developed DCS showed no difference in complement activation during dives compared to healthy
subjects (Shastri 1997).
Finally, a history of cigarette smoking may predispo se an individual to DCS. A retrospective analysis of
the Divers Alert Network (DAN) database found that heavy smokers (>15 pack-year history) were 1.88
times more likely to have DCS than divers who had never smoked and 1.56 times more likely than light
smokers (0-15 pack-year history) (Buch 2003).
Environmental Factors
Fluid balance appears to play a role in DCS. One study randomized swine subjects into two groups: a
hydrated group that was allowed ad lib access to water during a simulated saturation dive, and a
dehydrated group that was given intravenous furosemide without access to water. The dehydrated group
showed a significantly increased rate and faster onset of DCS and death, possibly due to increased bubble
formation or altered nitrogen removal (Fahlman 2006).
Ambient temperature has also been considered as a risk factor for DCS. A Navy study sought to compare
the incidence of DCS in divers who were immersed in air decompression dives to 120 feet of seawater at
either 97°F or 80°F, and found that warm conditions during bottom time and cold conditions during
decompression increased the risk of DCS, but this finding was confounded by dehydration (Gerth 2007).
Other studies found that hot water suits were 1.81 to 1.96 times more likely than passive thermal
protection to be associated with DCS, although some of these findings might have been attributable to the
dive profile or bottom time (Leffler 2001). It has been proposed that increased susceptibility to DCS may
result from increased gas uptake in warm conditions and decreased elimination in cold conditions, but
there is insufficient data to confirm this theory (Toner 2004).
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CONCLUSION
7KHabHlHEy EoLWdHcE an HndHvHGaFWIscQ EHbHQyLYdecompression sickness in hypobaric environments
would be advantageous for astronaut selection, crew assignment, and mission planning. To date, much
focus has been on PFO as a risk factor for DCS, but a number of other individual parameters as well as
environmental factors have also been implicated in increased risk of DCS. Although diving exposures
were once considered analogous to altitude exposures, there is increasing appreciation for the
fundamental differences between diving and altitude. There continues to be a need for altitude research
under controlled conditions to evaluate potential risk factors for DCS in altitude exposures and apply
knowledge about individual susceptibilities to mission planning. In the meantime, it seems sensible to
continue current protective measures such as exercise-enhanced prebreathe periods to minimize the risk
of DCS in hypobaric environments.
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